Cannabis finance news

Cannabiz launches awards program to celebrate an industry changing lives

by cannabiz team March 9, 2023April 30, 2024

Today sees the launch of the inaugural Cannabiz Awards for Australia and New Zealand 2023. The […]

Hope for Medlab to continue ‘in some shape or form’ as consultants weigh up variety of potential deals

by Steve Jones March 9, 2023April 30, 2024

Company news: Vitura Health; Puro; MGC Pharma; Incannex; Cann Global

by Steve Jones March 8, 2023April 30, 2024

Bod Science clears stability hurdle for Aqua Phase deal but PK study delayed

by Steve Jones March 7, 2023April 30, 2024

Medlab goes up for sale as directors appoint external consultants

by Steve Jones March 7, 2023April 30, 2024

Medlab cancels studies and directors depart as ASX suspends shares

by Steve Jones March 2, 2023April 30, 2024

Financial results: Elixinol; Emyria; Epsilon; Avecho; Creso Pharma; AusCann; MGC Pharma; Botanix; Zelira

by Martin Lane and Steve Jones March 1, 2023April 30, 2024

Company news: Eqalis/Novachem; Cann Group; Vitura Health; Incannex; Lyphe Group

by Steve Jones and Martin Lane March 1, 2023April 30, 2024

Cann Group to focus on ‘production at scale’ as new CEO beds down

by Steve Jones February 28, 2023April 30, 2024

ECS Botanics grows H1 revenue and cuts losses despite impact of heavy flooding

by Steve Jones February 28, 2023April 30, 2024